Brian Abrahams Analyst Performance

Analyst at Royal Bank Of Canada

Brian Abrahams is a stock analyst at Royal Bank Of Canada in the medical sector, covering 44 publicly traded companies. Over the past year, Brian Abrahams has issued 56 stock ratings, including buy and hold recommendations. While full access to Brian Abrahams' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Brian Abrahams' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

252 Last 10 Years

Buy Recommendations

70.92% 178 Buy Ratings

Companies Covered

44 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	70.9%	178 ratings
Hold	29.1%	73 ratings
Sell	0.0%	0 ratings

Out of 251 total stock ratings issued by Brian Abrahams at Royal Bank Of Canada, the majority (70.9%) have been Buy recommendations, followed by 29.1% Hold.

Best & Worst Calls

• Best Call

  0000.0%

  SAGE

  Apr 2020

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.
• Worst Call

  000.0%

  SRRA

  May 2016

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	97.7% of companies on NASDAQ	43 companies
NYSE	2.3% of companies on NYSE	1 company

Brian Abrahams, an analyst at Royal Bank Of Canada, currently covers 44 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 44 companies	100.0%

Brian Abrahams of Royal Bank Of Canada specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 25 companies	56.8%
PHARMACEUTICAL PREPARATIONS 11 companies	25.0%
MED - DRUGS 5 companies	11.4%
BIOTECHNOLOGY 2 companies	4.5%
MED - OUTP/HM CRE 1 company	2.3%

About Brian Abrahams

Dr. Brian Abrahams joined RBC Capital Markets in July 2017 as a senior analyst covering the biotechnology sector. He has 15 years of experience following large, mid, and small cap biotech companies, and prior to RBC spent time in biotechnology equity research at Jefferies, Wells Fargo, and CIBC World Markets / Oppenheimer & Co. He is a licensed non-practicing physician and holds a medical degree from the Albert Einstein College of Medicine. He did his undergraduate studies at Yale University, where he graduated magna cum laude with a Bachelor of Science degree in Molecular Biophysics & Biochemistry.

Follow on LinkedIn

Brian Abrahams' Ratings History at Royal Bank Of Canada

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
KYMR Kymera Therapeutics	9/16/2025	Initiated Coverage	$47.28	$70.00	Outperform	$0.00 00.00% ROI
NBIX Neurocrine Biosciences	9/5/2025	Boost Price Target	$143.76	$149.00	Outperform	$0.00 00.00% ROI
SION Sionna Therapeutics	9/3/2025	Initiated Coverage	$25.39	$22.00	Sector Perform	$0.00 00.00% ROI
XENE Xenon Pharmaceuticals	9/2/2025	Reiterated Rating	$39.12	$55.00	Outperform	$0.00 00.00% ROI
AARD Aardvark Therapeutics	8/14/2025	Lower Price Target	$11.44	$19.00	Outperform	$0.00 00.00% ROI
XENE Xenon Pharmaceuticals	8/12/2025	Lower Price Target	$36.96	$55.00	Outperform	$0.00 00.00% ROI
PTCT PTC Therapeutics	8/8/2025	Reiterated Rating	$46.87	$63.00	Outperform	$0.00 00.00% ROI
ETNB 89BIO	8/8/2025	Lower Price Target	$8.92	$11.00	Sector Perform	$0.00 00.00% ROI
GILD Gilead Sciences	8/8/2025	Boost Price Target	$119.21	$98.00	Sector Perform	$0.00 00.00% ROI
ACAD ACADIA Pharmaceuticals	8/7/2025	Boost Price Target	$23.84	$40.00	Outperform	$0.00 00.00% ROI
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
VRTX Vertex Pharmaceuticals	8/5/2025	Lower Price Target	$389.93	$405.00	Sector Perform	$0.00 00.00% ROI
PRTA Prothena	8/5/2025	Lower Price Target	$7.28	$10.00	Sector Perform	$0.00 00.00% ROI
REGN Regeneron Pharmaceuticals	8/4/2025	Boost Price Target	$569.71	$695.00	Sector Perform	$0.00 00.00% ROI
BIIB Biogen	8/1/2025	Boost Price Target	$126.28	$219.00	Outperform	$0.00 00.00% ROI
NBIX Neurocrine Biosciences	7/31/2025	Lower Price Target	$129.41	$144.00	Outperform	$0.00 00.00% ROI
INCY Incyte	7/30/2025	Boost Price Target	$77.88	$72.00	Sector Perform	$0.00 00.00% ROI
SRPT Sarepta Therapeutics	7/17/2025	Lower Price Target	$21.46	$23.00	Sector Perform	$0.00 00.00% ROI
BCRX BioCryst Pharmaceuticals	6/30/2025	Reiterated Rating	$9.23	$13.00	Outperform	$0.00 00.00% ROI
BIIB Biogen	6/25/2025	Set Price Target	$126.16	$213.00	Outperform	$0.00 00.00% ROI
CDTX Cidara Therapeutics	6/24/2025	Upgrade	$49.86	$75.00		$0.00 00.00% ROI
ACAD ACADIA Pharmaceuticals	6/23/2025	Boost Price Target	$22.12	$38.00	Outperform	$0.00 00.00% ROI
VRTX Vertex Pharmaceuticals	6/17/2025	Set Price Target	$448.47	$420.00	Sector Perform	$0.00 00.00% ROI
REGN Regeneron Pharmaceuticals	5/27/2025	Reiterated Rating	$599.20	$662.00	Sector Perform	$0.00 00.00% ROI
CTNM Contineum Therapeutics	5/15/2025	Reiterated Rating	$3.72	$31.00	Outperform	$0.00 00.00% ROI
KPTI Karyopharm Therapeutics	5/13/2025	Lower Price Target	$5.40	$33.00	Outperform	$0.00 00.00% ROI
XENE Xenon Pharmaceuticals	5/13/2025	Lower Price Target	$29.93	$55.00	Outperform	$0.00 00.00% ROI
CRBP Corbus Pharmaceuticals	5/7/2025	Lower Price Target	$6.34	$58.00	Outperform	$0.00 00.00% ROI
VRTX Vertex Pharmaceuticals	5/6/2025	Boost Price Target	$434.64	$423.00	Sector Perform	$0.00 00.00% ROI
BCRX BioCryst Pharmaceuticals	5/6/2025	Reiterated Rating	$10.40	$13.00	Outperform	$0.00 00.00% ROI
BIIB Biogen	5/2/2025	Lower Price Target	$122.38	$205.00	Outperform	$0.00 00.00% ROI
INCY Incyte	4/30/2025	Boost Price Target	$61.11	$67.00	Sector Perform	$0.00 00.00% ROI
REGN Regeneron Pharmaceuticals	4/30/2025	Lower Price Target	$586.51	$943.00	Outperform	$0.00 00.00% ROI
LEGN Legend Biotech	4/22/2025	Reiterated Rating	$33.48	$84.00	Outperform	$0.00 00.00% ROI
BIIB Biogen	4/22/2025	Boost Price Target	$117.63	$225.00	Outperform	$0.00 00.00% ROI
NBIX Neurocrine Biosciences	4/14/2025	Upgrade	$90.87	$137.00	Outperform	$0.00 00.00% ROI
BCRX BioCryst Pharmaceuticals	4/11/2025	Reiterated Rating	$6.55	$11.00	Outperform	$0.00 00.00% ROI
VRTX Vertex Pharmaceuticals	4/1/2025	Boost Price Target	$487.06	$420.00	Sector Perform	$0.00 00.00% ROI
SRPT Sarepta Therapeutics	3/31/2025	Downgrade	$70.41	$87.00	Sector Perform	$0.00 00.00% ROI
MLTX MoonLake Immunotherapeutics	3/18/2025	Initiated Coverage	$38.67	$67.00	Outperform	$0.00 00.00% ROI
AARD Aardvark Therapeutics	3/10/2025	Initiated Coverage	$10.13	$21.00	Outperform	$0.00 00.00% ROI
GHRS GH Research	3/7/2025	Initiated Coverage	$10.55	$31.00	Outperform	$0.00 00.00% ROI
SRPT Sarepta Therapeutics	2/27/2025	Lower Price Target	$107.24	$161.00	Outperform	$0.00 00.00% ROI
BCRX BioCryst Pharmaceuticals	2/25/2025	Reiterated Rating	$8.11	$11.00	Outperform	$0.00 00.00% ROI
PRTA Prothena	2/21/2025	Lower Price Target	$15.61	$20.00	Sector Perform	$0.00 00.00% ROI
KPTI Karyopharm Therapeutics	2/20/2025	Reiterated Rating	$9.41	$45.00	Outperform	$0.00 00.00% ROI
VRTX Vertex Pharmaceuticals	2/20/2025	Boost Price Target	$475.68	$408.00	Sector Perform	$0.00 00.00% ROI
BIIB Biogen	2/13/2025	Lower Price Target	$135.56	$225.00	Outperform	$0.00 00.00% ROI
GILD Gilead Sciences	2/12/2025	Boost Price Target	$103.52	$90.00	Sector Perform	$0.00 00.00% ROI
INCY Incyte	2/11/2025	Lower Price Target	$68.30	$68.00	Sector Perform	$0.00 00.00% ROI
VRTX Vertex Pharmaceuticals	2/11/2025	Boost Price Target	$459.15	$407.00	Sector Perform	$0.00 00.00% ROI
PLRX Pliant Therapeutics	2/10/2025	Downgrade	$7.79	$4.00	Sector Perform	$0.00 00.00% ROI
KPTI Karyopharm Therapeutics	2/10/2025	Reiterated Rating	$9.77	$45.00	Outperform	$0.00 00.00% ROI
NBIX Neurocrine Biosciences	2/7/2025	Lower Price Target	$122.00	$148.00	Sector Perform	$0.00 00.00% ROI
GILD Gilead Sciences	2/3/2025	Reiterated Rating	$99.12	$84.00	Sector Perform	$0.00 00.00% ROI
AXSM Axsome Therapeutics	1/29/2025	Reiterated Rating	$104.53	$139.00	Outperform	$0.00 00.00% ROI
ITCI Intra-Cellular Therapies	1/22/2025	Reiterated Rating	$127.40	$132.00	Sector Perform	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.